Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro- striatal pathway

Brain Research

Volumn 797, Issue 2, 1998, Pages 255-266

  Andrés, María Estela ^a   Gysling, Katia ^a   Bustos, Gonzalo ^a  

^a Lab of Biochemical Pharmacology   (Chile)

Author keywords

6 Hydroxydopamine lesion; DOPAC; Dopamine; NMDA; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; EXTRACELLULAR MATRIX; MICRODIALYSIS; MOTOR ACTIVITY; NERVE INJURY; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN CHEMISTRY; CORPUS STRIATUM; DENERVATION; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NEURAL PATHWAYS; OXIDOPAMINE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANTIA NIGRA; SYMPATHOLYTICS;

EID: 0032578002     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00381-3     Document Type: Article

References (73)

1. J. Abarca, G. Bustos, Basal and evoked release of GLU, ASP and GABA in rat corpus striatum: changes following partial DAergic neuronal denervation, Abstr. Chilean Biol. Soc. 3 (1995) 136 pp.
2. Abercrombie E.D., Bontz E., Zigmond M.J. Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525:1990;36-44.
3. Acheson A.L., Zigmond M.J., Stricker E.M. Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine. Science. 207:1980;537-540.
4. Agid Y., Javoy F., Glowinski J. Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigro-striatal dopaminergic system in the rat. Nature New Biol. 245:1973;150-151.
5. Aliaga E., Bustos G., Gysling K. Release of endogenous catecholamines from the striatum and bed nucleus of stria terminalis evoked by potassium and N-methyl-D-aspartate: in vitro microdialysis studies. J. Neurosci. Res. 40:1995;89-98.
6. Altar C.A., O'Neil S., Marshall J.F. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutirate in awake rats. Neuropharmacology. 23:1984;309-318.
7. Altar C.A., Marien M.R., Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: Implications for behavioral recovery from brain injury. J. Neurochem. 48:1987;390-399.
8. Altar C.A., Marien M.R. Preservation of dopamine release in the denervated striatum. Neurosci. Lett. 96:1989;329-334.
9. Andrés M.E., Gysling K., Araneda S., Venegas A., Bustos G. NMDA-NR1 receptor subunit mRNA expression in rat brain after 6-OH-dopamine induced lesions: a non-isotopic in situ hybridization study. J. Neurosci. Res. 46:1996;375-384.
10. M.E. Andrés, K. Gysling, G. Bustos, Regulation of dopamine release by N-methyl-D-aspartate in the striatum of rats with partial dopamine-nigrostriatal lesion, Soc. Neurosci. Abstr. 22 (1996) 1535 pp.
11. Araneda R., Bustos G. Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra. J. Neurochem. 52:1989;962-970.
12. Arias-Montaño J.A., Martínez-Fong D., Aceves J. Glutamate stimulation of tyrosine hydroxylase is mediated by NMDA receptors in the rat striatum. Brain Res. 569:1992;317-322.
13. Bernheiner H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20:1973;415-455.
14. Bouyer J.J., Park D.H., Joh T.H., Pickel V.C. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302:1984;267-275.
15. Carroza D.P., Ferraro T.N., Golden G.T., Reyes P.F., Hare T.A. In vivo modulation of excitatory amino acid receptors: Microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists. Brain Res. 574:1992;42-48.
16. Carter R., L'Heureux, Scatton B. Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal dialysis study. J. Neurochem. 51:1988;462-468.
17. Castañeda T., Whishaw I.Q., Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J. Neurosci. 10:1990;1847-1854.
18. Chéramy A., Kemel M.L., Gauchy C., Desce J.M., Galli T., Barbeito L., Glowinski J. Role of excitatory amino acids in the direct and indirect presynaptic regulation of dopamine release from nerve terminals of nigrostriatal dopaminergic neurons. Amino Acids. 1:1991;351-363.
19. Chéramy A., Desce J.M., Godeheu G., Glowinski J. Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes. Neurochem. Int. 25:1994;145-154.
20. Clow D.W., Jhamandas K. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J. Pharmacol. Exp. Ther. 248:1989;722-728.
21. Creese I., Burt D.R., Snyder S.H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science. 197:1977;596-598.
22. Desce J.M., Godeheu G., Galli T., Glowinski J., Chéramy A. Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes. Brain Res. 640:1994;205-214.
23. Desce J.M., Godeheu G., Galli T., Artaud F., Chéramy A., Glowinski J. L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience. 47:1992;333-339.
24. Emmi A., Rajabi H., Stewart J. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP. J. Neurosci. 16:1996;5216-5224.
25. Fonnum F., Storm-Mathisen J., Divac I. Biochemical evidence of glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain. Neuroscience. 6:1981;863-873.
26. Freund T.F., Powell J.F., Smith A.D. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons with particular reference to dendritic spines. Neuroscience. 13:1984;1189-1215.
27. Galli T., Desce J.M., Artaud F., Kemel M.L., Chéramy A., Glowinski J. Modulation of GABA release by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate and N-methyl-D-aspartate receptors in matrix-enriched areas of the rat striatum. Neuroscience. 50:1992;769-780.
28. Garris P.A., Walker Q.D., Wightman R.M. Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals. Brain Res. 753:1997;225-234.
29. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. TINS. 13:1990;244-253.
30. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4:1984;2877-2890.
31. Hefti F., Melamed E., Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res. 195:1980;123-137.
32. Hefti F., Enz A., Melamed E. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs. Neuropharmacology. 24:1985;19-23.
33. Herrera-Marschitz M., Meana J.J., O'Connor W.T., Goiny M., Reid M.S., Ungerstedt U. Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions. Amino Acids. 2:1992;157-179.
34. O. Hornykiewicz, S.J. Kish, Biochemical pathophysiology of Parkinson's disease, in: M.D. Yahr, K.J. Bergmann (Eds.), Advances in Neurology, Raven Press, New York, 1986.
35. Imperato A., Scrocco M.G., Bacchi S., Angelucci L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187:1990;55-556.
36. Johnson K.M., Jeng Y.J. Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals. Can. J. Physiol. Pharmacol. 69:1991;1416-1421.
37. Keefe K.A., Zigmond M.J., Abercrombie E.D. In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. J. Neural Transm. 91:1993;223-240.
38. Kornhuber J., Kornhuber M.E. Axo-axonic synapses in the rat striatum. Eur. Neurol. 22:1983;433-436.
39. Krebs M.O., Desce J.M., Kemel M.L., Gauchy C., Godeheu G., Chéramy A., Glowinski J. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:1991;81-85.
40. Krebs M.O., Kemel M.L., Gauchy C., Desban M., Glowinski J. Local gabaergic regulation of the N-methyl-D-aspartate-evoked release of dopamine is more prominent in striosomes than in matrix of the rat striatum. Neuroscience. 57:1993;249-260.
41. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin-phenol reagent. J. Biol. Chem. 193:1951;265-276.
42. Marshall J.F. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control. Brain Res. 177:1979;311-324.
43. McGeer P.L., McGeer E.G., Scherer U., Singh K. A glutamatergic corticostriatal path. Brain Res. 128:1977;369-373.
44. Menegoz M., Lau L.F., Herve D., Huganir R.L., Girault J.A. Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions. NeuroReport. 7:1995;125-128.
45. Miller D.W., Abercrombie E.D. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res. Bull. 40:1996;57-62.
46. Mishra R.K., Gardner E.L., Katzman R., Makman M.H. Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity. PNAS. 71:1974;3883-3887.
47. Moghadam B., Gruen R.J. Do endogenous excitatory amino acids influence striatal dopamine release? Brain Res. 544:1991;329-330.
48. Molina-Holgado E., Dewar K.M., Descarries L., Reader T.A. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 270:1994;713-721.
49. Morari M., O'Connor W.T., Ungerstedt U., Fuxe K. N-methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study. J. Neurochem. 60:1993;1884-1893.
50. Morari M., O'Connor W.T., Ungerstedt U., Fuxe K. Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid. Eur. J. Pharmacol. 256:1994;23-30.
51. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
52. Porter R.H.P., Greene J.G., Higgins D.S. Jr., Greenamyre J.T. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci. 14:1994;7192-7199.
53. Richard M.G., Bennett J.P. Jr. NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions. J. Neurochem. 64:1995;2080-2086.
54. Robinson T.E., Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from partial unilateral 6-OHDA lesion of the substantia nigra: microdialysis study in freely moving rats. Brain Res. 450:1988;209-224.
55. Robinson T.E., Mocsary Z., Camp D.M., Whishaw I.Q. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J. Neurosci. 14:1994;2687-2696.
56. 3H] 3-(2-Carboxypiperazin-4-yl) propyl-1-phosphonic acid binding J. Neurochem. 54:1990;1926-1933.
57. Smith A.D., Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. TINS. 13:1990;259-265.
58. Snyder R., Keller W. Jr., Zigmond M.J. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J. Pharmacol. Exp. Ther. 253:1990;867-876.
59. Soares-Da-Silva P., Garret M.C. A kinetic study of the rate formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: implications for the origin of DOPAC. Neuropharmacology. 29:1990;869-874.
60. Stachowiak M.K., Keller R.W. Jr., Stricker E.M., Zigmond M.J. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. J. Neurosci. 7:1987;1648-1654.
61. Tremblay M., Salin P., Soghomonian J.J. Effect of 6-OHDA lesions on striatal mRNA levels encoding for glutamate receptor subunits. NeuroReport. 6:1995;2225-2229.
62. Ulas J., Cotman C.W. Dopaminergic denervation of striatum results in elevated expression of NR2A subunit. NeuroReport. 7:1995;1789-1793.
63. Ulas J.F., Weihmuller B., Brunner L.C., Joyce J.N., Marshall J.F., Cotman C.W. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J. Neurosci. 14:1994;6317-6324.
64. Weihmuller F.B., O'Dell S.J., Marshall J.F. Alterations in striatal glutamate receptors following 6-OH-DA-induced damage to nigrostriatal dopamine neurons. Soc. Neurosci. Abstr. 19:1993;1678.
65. Weihmuller F.B., Ulas J.F., Nguyen L., Cotman C.W., Marshall J.F. Elevated NMDA receptors in Parkinsonian striatum. NeuroReport. 3:1992;977-980.
66. Westerinik B.H.C., Santiago M., De Vries J.B. The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;523-529.
67. Wüllner U., Testa C.M., Catania M.V., Young A.B., Penney J.B. Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res. 645:1994;98-102.
68. Young A.M.J., Bradford H.F. N-methyl-D-aspartate release γ-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method. J. Neurochem. 60:1993;487-492.
69. Zetterström T., Sharp T., Collin A.K., Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:1988;327-334.
70. Zhang W.Q., Tilson H.A., Nanry K.P., Hudson P.M., Hong J.S., Stachowiak M.K. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res. 461:1995;335-342.
71. Zigmond M.J., Stricker E.M. Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion. Experientia. 36:1980;436-438.
72. Zigmond M.J., Acheson A.L., Stachowiak M.K., Stricker E.M. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch. Neurol. 41:1984;856-861.
73. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. TINS. 13:1990;290-296.